Drivers and regulators of humoral innate immune responses to infection and cancer

被引:14
作者
Kumar, Deepak [1 ]
Romero, Yeni [2 ]
Schuck, Kaitlynn N. [1 ]
Smalley, Haley [3 ]
Subedi, Bibek [3 ]
Fleming, Sherry D. [3 ]
机构
[1] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA
[2] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA
[3] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA
基金
美国食品与农业研究所; 美国国家科学基金会;
关键词
Complement; B-1 B cells; Natural antibodies; Bacteria; Virus; Cancer; COMPLEMENT FACTOR-I; FACTOR-H-BINDING; NATURAL IGG ANTIBODIES; SIMPLEX-VIRUS TYPE-1; WEST-NILE-VIRUS; B-CELLS; ALTERNATIVE PATHWAY; B-1; CELLS; ESCHERICHIA-COLI; NEUTRALIZING ANTIBODIES;
D O I
10.1016/j.molimm.2020.03.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The complement cascade consists of cell bound and serum proteins acting together to protect the host from pathogens, remove cancerous cells and effectively links innate and adaptive immune responses. Despite its usefulness in microbial neutralization and clearance of cancerous cells, excessive complement activation causes an immune imbalance and tissue damage in the host. Hence, a series of complement regulatory proteins present at a higher concentration in blood plasma and on cell surfaces tightly regulate the cascade. The complement cascade can be initiated by B-1 B cell production of natural antibodies. Natural antibodies arise spontaneously without any known exogenous antigenic or microbial stimulus and protect against invading pathogens, clear apoptotic cells, provide tissue homeostasis, and modulate adaptive immune functions. Natural IgM antibodies recognize microbial and cancer antigens and serve as an activator of complement mediated lysis. This review will discuss advances in complement activation and regulation in bacterial and viral infections, and cancer. We will also explore the crosstalk of natural antibodies with bacterial populations and cancer.
引用
收藏
页码:99 / 110
页数:12
相关论文
共 180 条
[1]   How Escherichia coli Circumvent Complement-Mediated Killing [J].
Abreu, Afonso G. ;
Barbosa, Angela S. .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[2]   Complement Evasion Strategies of Viruses: An Overview [J].
Agrawal, Palak ;
Nawadkar, Renuka ;
Ojha, Hina ;
Kumar, Jitendra ;
Sahu, Arvind .
FRONTIERS IN MICROBIOLOGY, 2017, 8
[3]   Expression of complement factor H by lung cancer cells:: Effects on the activation of the alternative pathway of complement [J].
Ajona, D ;
Castaño, Z ;
Garayoa, M ;
Zudaire, E ;
Pajares, MJ ;
Martinez, A ;
Cuttitta, F ;
Montuenga, LM ;
Pio, R .
CANCER RESEARCH, 2004, 64 (17) :6310-6318
[4]   Enterococcus faecalis Escapes Complement-Mediated Killing via Recruitment of Complement Factor H [J].
Ali, Youssif M. ;
Sim, Robert B. ;
Schwaeble, Wilhelm ;
Shaaban, Mona I. .
JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (06) :1061-1070
[5]  
Alugupalli KR, 2008, CURR TOP MICROBIOL, V319, P105
[6]   The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes [J].
Alugupalli, KR ;
Gerstein, RM ;
Chen, JZ ;
Szomolanyi-Tsuda, E ;
Woodland, RT ;
Leong, JM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3819-3827
[7]   EXPRESSION OF HUMAN B CELL-ASSOCIATED ANTIGENS ON LEUKEMIAS AND LYMPHOMAS - A MODEL OF HUMAN B-CELL DIFFERENTIATION [J].
ANDERSON, KC ;
BATES, MP ;
SLAUGHENHOUPT, BL ;
PINKUS, GS ;
SCHLOSSMAN, SF ;
NADLER, LM .
BLOOD, 1984, 63 (06) :1424-1433
[8]   CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity [J].
Ansel, KM ;
Harris, RBS ;
Cyster, JG .
IMMUNITY, 2002, 16 (01) :67-76
[9]   T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction? [J].
Bachmann, MF ;
Hengartner, H ;
Zinkernagel, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) :3445-3451
[10]   Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells [J].
Barilla-LaBarca, ML ;
Liszewski, MK ;
Lambris, JD ;
Hourcade, D ;
Atkinson, JP .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6298-6304